Homocysteine metabolism and its relation to health and disease

BioFactors

Volumn 36, Issue 1, 2010, Pages 19-24

  Williams, Kelly T ^a   Schalinske, Kevin L ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Folate; Homocysteine; Hyperhomocysteinemia; Methyl group metabolism

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PLACEBO; PYRIDOXINE; S ADENOSYLMETHIONINE; VITAMIN B GROUP;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERHOMOCYSTEINEMIA; INTERVENTION STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; RETINA MACULA DEGENERATION; REVIEW; RISK REDUCTION; UNSPECIFIED SIDE EFFECT; VASCULAR DISEASE; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

GUANIDINOACETATE N-METHYLTRANSFERASE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; S-ADENOSYLMETHIONINE; VITAMIN B COMPLEX;

EID: 77951121781     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.71     Document Type: Review

References (75)

1. Schalinske, K. L. (2009) Hepatic sulfur amino acid metabolism. In Glutathione and Sulfur Amino Acids in Human Health and Disease (Masella, R. and Mazza, G., eds.). pp. 73-90, Wiley, Hoboken, New Jersey.
2. Kerr, S. J. (1972) Competing methyltransferase systems. J. Biol. Chem. 247, 4248-4252.
3. Cantoni, G. L. (1982) S-adenosylamino acids thirty years later: 1951-1981. In The Biochemistry of S-adenosylmethionine and Related Compounds (Usdin, E., Borchardt, R. T., and Creveling, C. R., eds.). pp. 3-10, MacMillan Press, London.
4. Cantoni, G. L. and Chiang, P. K. (1980) The role of S- adenosylhomocysteine and S-adenosylhomocysteine hydrolase in the control of biological methylations. In Natural Sulfur Compounds (Cavallini, D., Gaull, G. E., and Zappia, V., eds.). pp. 67-80, Plenum Press, New York.
5. McKeever, M. P., Weir, D. G., Molloy, A., and Scott, J. M. (1991) Betainehomocysteine methyltransferase: organ distribution in man, pig and rat and subcellular distribution in the rat. Clin. Sci. 81, 551-556.
6. Mudd, S. H. and Poole J. R. (1975) Labile methyl balances for normal humans on various dietary regimens. Metabolism 24, 721-735.
7. Mudd, S. H., Ebert, M. H., and Scriver C. R. (1980) Labile methyl group balances in the human: the role of sarcosine. Metabolism 29, 707-720.
8. Stead, L. M., Brosnan, J. T., Brosnan, M. E., Vance, D. E., and Jacobs R. L. (2006) Is it time to reevaluate methyl balance in humans? Am. J. Clin. Nutr. 83, 5-10.
9. Mudd, S. H., Brosnan, J. T., Brosnan, M. E., Jacobs, R. L., Stabler, S. P., Allen, R. H., Vance, D. E., and Wagner C. (2007) Methyl balance and transmethylation fluxes in humans. Am. J. Clin. Nutr. 85, 19-25.
10. Stead, L. M., Au, K. P., Jacobs, R. L., Brosnan, M. E., and Brosnan, J. T. (2001) Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate. Am. J. Physiol. Endocrinol. Metab. 281, E1095-E1100.
11. Yao, Z. M. and Vance, D. E. (1988) The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J. Biol. Chem. 263, 2998-3004.
12. Jacobs, R. L., Stead, L. M., Devlin, C., Tabas, I., Brosnan, M. E., Brosnan, J. T., and Vance, D. E. (2005) Physiological regulation of phospholipid methylation alters plasma homocysteine in mice. J. Biol. Chem. 280, 28299-28305.
13. Noga, A. A., Zhao, Y., and Vance, D. E. (2002) An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins. J. Biol. Chem. 277, 42358-42365.
14. Wagner, C. (1995) Biochemical role of folate in cellular metabolism. In Folate in Health and Disease (Bailey, L. B., ed.). pp. 23-42, Marcel Dekker, Inc., New York.
15. Luka, Z., Capdevila, A., Mato, J. M., and Wagner, C. A. (2006) Glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme. Transgenic Res. 15, 393-397. (Pubitemid 43901497)
16. Nieman, K. M., Hartz, C. S., Szegedi, S. S, Garrow, T. A., Sparks, J. D., and Schalinske, K. L. (2006) Folate status modulates the induction of hepatic glycine N-methyltransferase and homocysteine metabolism in diabetic rats. Am. J. Physiol. Endocrinol. Metab. 291, E1235-E1242.
17. Nieman, K. M., Rowling, M. J., Garrow, T. A., and Schalinske, K. L. (2004) Modulation of methyl group metabolism by streptozotocin-induced diabetes and all-trans-retinoic acid. J. Biol. Chem. 279, 45708-45712.
18. Ozias, M. K. and Schalinske, K. L. (2003) All-trans-retinoic acid rapidly induces glycine N-methyltransferase in a dose-dependent manner and reduces circulating methionine and homocysteine levels in rats. J. Nutr. 133, 4090-4094.
19. Rowling, M. J., McMullen, M. H., and Schalinske, K. L. (2002) Vitamin A and its derivatives induce hepatic glycine N-methyltransferase and hypomethylation of DNA in rats. J. Nutr. 132, 365-369.
20. Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuvel, L. P., and Rozen, R. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reducatse. Nat. Genet. 10, 111-113.
21. Jacques, P. F., Bostom, A. G., Williams, R. R., Ellison, R. C., Eckfeldt, J. H., Rosenberg, I. H., Selhub, J., and Rozen, R. (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 7-9. (Pubitemid 26006560)
22. Nelen, W. L. D. M., Blom, H. J., Thomas, C. M. G., Steegers, E. A. P., Boers, G. H. J., and Eskes, T. K. A. B. (1998) Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J. Nutr. 128, 1336-1341.
23. Chen, Z., Karaplis, A. C., Ackerman, S. L., Progribny, I. P., Melnyk, S., Lussier-Cacan, S., Chen, M. F., Pai, A., John, S. W., Smith, R. S., Bottiglieri, T., Bagley, P., Selhub, J., Rudnicki, M. A., James, S. J., and Rozen, R. (2001) Mice deficient in methylenetetrahydrofolatereductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 10, 433-443.
24. Beagle, B., Yang, T. L., Hung, J., Cogger, E. A., Moriarty, D. J., and Caudill, M. A. (2005) The glycine N-methyltransferase (GNMT) 1289 C->T variant influences plasma total homocysteine concentrations in young women after restricting folate intake. J. Nutr. 135, 2780-2785. (Pubitemid 43156541)
25. Caudill, M. A., Dellschaft, N., Solis, C., Hinkis, S., Ivanov, A. A., Mash-Barboza, S., Randall, K. E., Jackson, B., Solomita, G. N., and Vermeylen, F. (2009) Choline intake, plasma riboflavin, and the phosphatidylethanolamine N-methyltransferase G5465A genotype predict plasma homocysteine in folate-deplete Mexican-American men with the methyltenetetrahydrofolate reductase 677TT genotype. J. Nutr. 139, 727-733.
26. Vaughn, J. D., Bailey, L. B., Shelnutt, K. P., Dunwoody, K. M., Maneval, D. R., Davis, S. R., Quinlivan, E. P., Gregory, J. F. III, Theriaque, D. W., and Kauwell, G. P. (2004) Methionine synthase reductase 66A->G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofoalte reducgtase 677C->T variant. J. Nutr. 134, 2985-2990.
27. Ratnam, S., Wijekoon, E. P., Hall, B., Garrow, T. A., Brosnan, M. E., and Brosnan, J. T. (2006) Effects of diabetes and insulin on betaine-homocysteine S-methyltransferase expression in rat liver. Am. J. Physiol. Endocrinol. Metab. 290, E933-E999.
28. Ohuchi, S., Matsumoto, Y., Morita, T., and Sugiyama, K. (2009) High casein diet decreases plasma homocysteine concentration in rats. J. Nutr. Sci. Vitaminol. 55, 22-30.
29. Ohuchi, S., Morita, T., Mori, M., and Sugiyama, K. (2009) Hepatic cysthathionine b-synthase activity does not increase in response to methionine supplementation in rats fed a low casein diet: association with plasma homocysteine concentrations. J. Nutr. Sci. Vitaminol. 55, 178-185.
30. Collinsova, M., Strakova, J., Jiracek, J., and Garrow, T. A. (2006) Inhibition of betaine-homocysteine S-methyltransferase causes hyperhomocysteinemia in mice. J. Nutr. 136, 1493-1497. (Pubitemid 43765351)
31. Mudd, S. H., Levy, H. L., and Skovby, F. (1995) Disorders of transsulfuration. In The Metabolic and Molecular Basis of Inherited Disease (Scriver, C. R., Beaudt, W. S., Sly, D., and Valle, D., eds.). pp. 1279- 1327. McGraw-Hill, New York.
32. Wang, L., Jhee, K.-H., Hua, X., DiBello, P. M., Jacobsen, D. W., and Kruger, W. D. (2004) Modulation of cystathionine β-synthase level regulates total serum homocysteine in mice. Circ. Res. 94, 1318-1324.
33. Wijekoon, E. P., Hall, B., Ratnam, S., Brosnan, M. E., Zeisel, S. H., and Brosnan, J. T. (2005) Homocysteine metabolism in ZDF (type 2) diabetic rats. Diabetes 54, 3245-3251. (Pubitemid 43334381)
34. Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., and Graham, I. (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324, 1149-1155.
35. Kang, S.-S., Wong, P. W., and Malinow, M. R. (1992) Hyperhomocyst(e) inemia as a risk factor for occlusive vascular disease. Annu. Rev. Nutr. 12, 279-298.
36. Castro, R., Rivera, I., Blom, H. J., Jakobs, C., and Travares de Almeida, I. (2006) Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J. Inherit. Metab. Dis. 29, 3-20.
37. Kim, Y.-I. (1999) Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr. Rev. 57, 314-321.
38. Mattson, M. P. and Shea, T. B. (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 26, 137-146. (Pubitemid 36183675)
39. Steegers-Theunissen, R., Boers, G., Trijbels, F., Finkelstein, J., Blom, H., Thomas, C., Borm, G., Wouters, M., and Eskes, T. (1994) Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 43, 1475-1480.
40. Tessari, P., Coracina, A., Kiwanuka, E., Vedovato, M., Vettore, M., Valerio, A., Zaramella, M., and Garibotto, G. (2005) Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy. Diabetes 54, 2968-2976. (Pubitemid 41401094)
41. McCully, K. S. (2007) Homocysteine, vitamins, and vascular disease prevention. Am. J. Clin. Nutr. 86, 1563S-1568S.
42. McNulty, H., Pentieva, K., Hoey, L., and Ward, M. (2008) Homocysteine, B-vitamins and CVD. Proc. Nutr. Soc. 67, 232-237.
43. Chambers, J. C., Ueland, P. M., Obeid, O. A., Wrigley, J., Refsum, H., and Kooner, J. S. (2000) Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 102, 2479-4783.
44. Schnyder, G., Roffi, M., Flammer, Y., Pin, R., and Hess, O. M. (2002) Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA 288, 973-979. (Pubitemid 34920462)
45. Schnyder, G., Roffi, M., Pin, R., Flammer, Y., Lange, H., Eberli, F. R., Meier, B., Turi, Z. G., and Hess O. M. (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N. Engl. J. Med. 345, 1593-1600.
46. Title, L. M., Cummings, P. M., Giddens, K., Genest, J. J. Jr., and Nassar, B. A. (2000) Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J. Am. Coll. Cardiol. 26, 758-765.
47. Woo, K. S., Chook, P., Lolin, Y. I., Sanderson, J. E., Metreweli, C., and Celermajer, D. S. (1999) Folic acid improves arterial endothelial function in adults with hyperhomocysteinemia. J. Am. Coll. Cardiol. 34, 2002-2006.
48. Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., and Rasmussen, K.; NORVIT Trial Investigators. (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 354, 1578-1588.
49. Bleie, Ø., Semb, A. G., Grundt, H., Nordrehaug, J. E., Vollset, S. E., Ueland, P. M., Nilsen, D. W., Bakken, A. M., Refsum, H., and Nygård, O. K. (2007) Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. J. Intern. Med. 262, 244-253.
50. Ebbing, M., Bleie, Ø., Ueland, P. M., Nordrehaug, J. E., Nilsen, D. W., Vollset, S. E., Refsum, H., Pedersen, E. K., and Nygård, O. (2008) Mortality and cardiovascular events in patients treated with homocysteinelowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 300, 795-804.
51. Lonn, E., Yusuf, S., Arnold, M. J., Sheridan, P., Pogue, J., Micks, M., McQueen, M. J., Probstfield, J., Fodor, G., Held, C., Genest, J. Jr.; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 354, 1567-1577.
52. Potter, K., Hankey, G. J., Green, D. J., Eikelboom, J., Jamrozik, K., and Arnolda, L. F. (2008) The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis. BMC Cardiovasc. Disord. 8, 24.
53. Ray, J. G., Kearon, C., Yi, Q., Sheridan, P., and Lonn, E.; Heart Outcomes Prevention Evaluation 2 (HOPE-2) Investigators. (2007) Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial. Ann. Intern. Med. 146, 761-767.
54. Albert, C. M., Cook, N. R., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J. E., and Manson, J. E. (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 299, 2027-2036. (Pubitemid 351656584)
55. den Heijer, M., Willems, H. P., Blom, H. J., Gerrits, W. B., Cattaneo, M., Eichinger, S., Rosendaal, F. R., and Bos, G. M. (2007) Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial. Blood 109, 139-144. (Pubitemid 46053054)
56. Jamison, R. L., Hartigan, P., Kaufman, J. S., Goldfarb, D. S., Warren, S. R., Guarino, P. D., and Gaziano, J. M. (2007) Veterans affairs site investigators. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 298, 1163-1170.
57. Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C. H., and Stampfer, M. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA 291, 565-575.
58. Potter, K., Lenzo, N., Eikelboom, J. W., Arnolda, L. F., Beer, C., and Hankey, G. J. (2009) Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial. Cerebrovasc. Dis. 27, 259-265.
59. Mann, J. F., Sheridan, P., McQueen, M. J., Held, C., Arnold, J. M. O., Fodor, G., Yusuf, S., and Lonn, E. M.; HOPE-2 Investigators. (2008) Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease - results of the renal Hope-2 study. Nephrol. Dial. Transplant. 23, 645-653.
60. Dusitanond, P., Eikelboom, J. W., Hankey, G. J., Thom, J., Gilmore, G., Loh, K., Yi, Q., Klijn, C. J., Langton, P., van Bockxmeer, F. M., Baker, R., and Jamrozik, K. (2005) Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial. Stroke 36, 144-146. (Pubitemid 40054191)
61. Nafar, M., Khatami, F., Kardavani, B., Farjad, R., Pour-Reza-Gholi, F., Firouzan, A., Kalantar, A., Farhangi, S., and Einollahi, B. (2009) Role of folic acid in atherosclerosis after kidney transplant: a double-blind, randomized, placebo-controlled clinical trial. Exp. Clin. Transplant. 7, 33-39.
62. Moens, A. L., Claeys, M. J., Wuyts, F. L., Goovaerts, I., Van Hertbruggen, E., Wendelen, L. C., Van Hoof, V. O., and Vrints, C. J. (2007) Effect of folic acid on endothelial function following acute myocardial infarction. Am. J. Cardiol. 99, 476-481.
63. Title, L. M., Ur, E., Giddens, K., McQueen, M. J., and Nassar, B. A. (2006) Folic acid improves endothelial dysfunction in type 2 diabetes - an effect independent of homocysteine-lowering. Vasc. Med. 11, 101-109.
64. Held, C., Sumner, G., Sheridan, P., McQueen, M., Smith, S., Dagenais, G., Yusuf, S., and Lonn, E. (2008) Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the homocysteine and atherosclerosis reduction trial (HART). Vasc. Med. 13, 245-253.
65. Bostom, A. G., Carpenter, M. A., Hunsicker, L., Jacques, P. F., Kusek, J. W., Levey, A. S., McKenney, J. L., Mercier, R. Y., Pfeffer, M. A., and Selhub, J.; FAVORIT Study Investigators. (2009) Baseline characteristics of participants in the folic acid for vascular outcome reduction in transplantation (FAVORIT) trial. Am. J. Kidney Dis. 53, 121-128.
66. Kang, J. H., Cook, N., Manson, J., Buring, J. E., Albert, C. M., and Grodstein, F. (2008) A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am. J. Clin. Nutr. 88, 1602-1610.
67. Aisen, P. S., Schneider, L. S., Sano, M., Diaz-Arrastia, R., van Dyck, C. H., Weiner, M. F., Bottiglieri, T., Jin, S., Stokes, K. T., Thomas, R. G., and Thal, L. J.; Alzheimer Disease Cooperative Study. (2008) High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 300, 1774-1783.
68. Sun, Y., Lu, C. J., Chien, K. L., Chen, S. T., and Chen, R. C. (2007) Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients. Clin. Ther. 29, 2204-2214.
69. Song, Y., Cook, N. R., Albert, C. M., Van Denburgh, M., and Manson, J. E. (2009) Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 diabetes mellitus in women: a randomized controlled trial. Diabetes 58, 1921-1928.
70. Herrmann, M., Umanskaya, N., Traber, L., Schmidt-Gayk, H., Menke, W., Lanzer, G., Lenhart, M., Peter Schmidt, J., and Herrmann, W. (2007) The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial. Clin. Chem. Lab. Med. 45, 1785-1792.
71. Herrmann, M., Stanger, O., Paulweber, B., Hufnagl, C., and Herrmann, W. (2006) Folate supplementation does not affect biochemical markers of bone turnover. Clin. Lab. 52, 131-136.
72. Sato, Y., Honda, Y., Iwamoto, J., Kanoko, T., and Satoh, K. (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293, 1082-1088. (Pubitemid 40300282)
73. Christen, W. G., Glynn, R. J., Chew, E. Y., Albert, C. M., and Manson, J. E. (2009) Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the women's antioxidant and folic acid cardiovascular study. Arch. Intern. Med. 169, 335-341.
74. Saposnik, G., Ray, J. G., Sheridan, P., McQueen, M., and Lonn, E.; Heart Outcomes Prevention Evaluation 2 Investigators. (2009) Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke 40, 1365-1372.
75. Hodis, H. N., Mack, W. J., Dustin, L., Mahrer, P. R., Azen, S. P., Detrano, R., Selhub, J., Alaupovic, P., Liu, C. R., Liu, C. H., Hwang, J., Wilcox, A. G., and Selzer, R. H.; BVAIT Research Group. (2009) High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial. Stroke 40, 730-736.